Latanoprost eye drops increase concentration of glycosaminoglycans in posterior rabbit sclera

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 3, 2004, Pages 185-188

  Trier, Klaus ^a   Ribel Madsen, Søren Munk ^a  

^a Trier Eye Clin and Res Labs   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; DACRIOSOL; DEXTRAN 70; EYE DROPS; GLYCOSAMINOGLYCAN; HYDROXYPROPYLMETHYLCELLULOSE; LATANOPROST; UNCLASSIFIED DRUG; URONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CILIARY BODY; CONNECTIVE TISSUE; CONTROLLED STUDY; CORNEA; DRUG EFFECT; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; NONHUMAN; PUNCH BIOPSY; QUANTITATIVE ANALYSIS; RABBIT; SCLERA; SPECTROPHOTOMETRY;

ANIMALS; CORNEA; FEMALE; GLYCOSAMINOGLYCANS; INSTILLATION, DRUG; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; RABBITS; SCLERA; SPECTROPHOTOMETRY; URONIC ACIDS;

EID: 3042807194     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/1080768041223648     Document Type: Article

References (9)

1. Lindsey, J.D., Kashiwagi, K., Kashiwagi, F., and Weinreb, R.N. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest. Ophthalmol. Vis. Sci. 38:2214-2223, 1997.
2. Ocklind, A. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp. Eye Res. 67:179-191, 1998.
3. Sagara, T., Gaton, D.D., Lindsey, J.D., Gabelt, B.T., Kaufmann, P.L., and Weinreb R.N. Topical prostaglandin F2 treatment reduces collagen types I,III, and IV in the monkey uveoscleral outflow pathway. Arch. Ophthalmol. 117:794-801, 1999.
4. Kim, J, Lindsey, J.D., Wang, N., and Weinreb, R.N. Increased human scleral permeability with prostaglandin exposure. Invest. Ophthalmol. Vis. Sci. 42:1514-1521, 2001.
5. Blumenkrantz, N. and Asboe-Hansen, G. New method for quantitative determination of uronic acids. Analytical Biochem 54:484-489, 1973.
6. Sjoquist, B., Basu, S., Byding, P., Bergh, K., and Stjernschantz, J. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit. Drug Metab. Dispos. 26:745-754, 1998.
7. Bito, L.Z., Camras, C.B., and Gum, G.G. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. Prog. Clin. Biol. Res. 312:349-68, 1998.
8. Nomura, S. and Hashimoto, M. Pharmacological profiles of latanoprost (Xalatan), a novel anti-glaucoma drug. Nippon Yakurigaku Zasshi 115(5):280-286, 2000.
9. Quigley, H.A., Dorman Pease, M.E., and Brown, A.E. Quantitative study of collagen and elastin of the optic nerve head and sclera in human and experimental monkey glaucoma. Curr. Eye Res. 10:877-888, 1991.